Richard P. Shannon

Duke University — United States

Medicine · Health Sciences

57h-index13.4kcitations201works2.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiovascular Function and Risk Factors(50), Heart Failure Treatment and Management(32), Cardiac electrophysiology and arrhythmias(27), Diabetes Treatment and Management(20), Heart Rate Variability and Autonomic Control(16)

Publications201 total

Multimodal quality improvement project on reducing hospital perioperative thromboembolic events (Patient Safety Indicator-12)
BMJ Open Quality·2025Open Access
Incorporating Acute Conditions into Risk-Adjustment for Provider Profiling: The Case of the US News and World Report Best Hospitals Rankings Methodology
American Journal of Medical Quality·2024· 4 citedOpen Access
Interactive visualization tool to understand and monitor health disparities in diabetes care and outcomes
Journal of Clinical and Translational Science·2024· 3 citedOpen Access
Development of an interactive dashboard for gun violence pattern analysis and intervention design at the local level
JAMIA Open·2023· 2 citedOpen Access
List of Contributors
Elsevier eBooks·2017
Animal Models for Cardiovascular Research
Elsevier eBooks·2017· 3 cited
Building the Pipeline
Academic Medicine·2014· 42 citedOpen Access
Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass
Surgery for Obesity and Related Diseases·2014· 12 citedOpen Access
GLP-1 (7–36) amide restores myocardial insulin sensitivity and prevents the progression of heart failure in senescent beagles
Cardiovascular Diabetology·2014· 9 citedOpen Access
GLP-1(32–36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogs
Peptides·2014· 29 citedOpen Access
The use of participatory action research to design a patient-centered community health worker care transitions intervention
Healthcare·2014· 62 cited
Patient-Centered Community Health Worker Intervention to Improve Posthospital Outcomes
JAMA Internal Medicine·2014· 272 cited
Beyond Glycemic Control: Cardiovascular Effects of Incretin-Based Therapies
Frontiers of hormone research·2014· 6 cited
The Glucoregulatory Benefits of Glucagon-Like Peptide-1 (7-36) Amide Infusion During Intensive Insulin Therapy in Critically Ill Surgical Patients
Critical Care Medicine·2013· 33 citedOpen Access
Incretin-based therapies: can we achieve glycemic control and cardioprotection?
Journal of Endocrinology·2013· 27 citedOpen Access
Understanding Why Patients Of Low Socioeconomic Status Prefer Hospitals Over Ambulatory Care
Health Affairs·2013· 439 cited
DPP-4 Inhibition and Neuroprotection: Do Mechanisms Matter?
Diabetes·2013· 35 citedOpen Access
Animal Models for Cardiovascular Research
Elsevier eBooks·2013· 5 cited
Understanding Why Patients Of Low Socioeconomic Status Prefer Hospitals Over
2013
List of Contributors
Elsevier eBooks·2013
page 1 of 11Next →

Frequent Co-authors

Stephen F. Vatner(15), Dariush Elahi(8), Dorothy E. Vatner(8), Jeffrey M. Testani(7), Sanford P. Bishop(7), Kazuo Komamura(7), C J Homcy(6), Lazaros A. Nikolaidis(5), Stephen E. Kimmel(5), You‐Tang Shen(5), Masami Uechi(5), Yoshihiro Ishikawa(5), Thomas E. Wagner(4), Kuniya Asai(4), Sunil Mankad(3), George Sokos(3), Brian D. McCauley(3), Indu Poornima(3), Pratik Parikh(3), Teresa Hentosz(3)